Lung-Specific Expression of Adenovirus E3-14.7K in Transgenic Mice Attenuates Adenoviral Vector-Mediated Lung Inflammation and Enhances Transgene Expression
- 1 September 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (13) , 1885-1898
- https://doi.org/10.1089/hum.1998.9.13-1885
Abstract
Herein, we report that the adenovirus E3-14.7K protein inhibits the inflammatory response to adenovirus in transgenic mice in which the E3-14.7K gene was selectively expressed in the respiratory epithelium, using the human surfactant protein C (SP-C) promoter. E3-14.7K mRNA and protein were detected specifically in the lungs of SPC/E3-14.7K transgenic mice. Responses of the transgenic mice to Av1Luc1, an E1–E3-deleted Ad vector encoding the luciferase reporter gene, were examined, including vector transgene expression and lung inflammation. In wild-type mice, luciferase activity declined rapidly and was lost 14 days following Av1Luc1 administration. The loss of luciferase activity was associated with pulmonary infiltration by macrophages and lymphocytes. In heterozygous SPC/E3-14.7K mice, luciferase activity was increased by 7 days compared with control littermates, and pulmonary infiltration by macrophages was decreased. In homozygous (+/+) SPC/E3-14.7K mice, luciferase activity was increased 7, 14, and 21 days following administration compared with wild-type mice, and lung inflammation was markedly reduced. After Av1Luc1 administration, PCNA staining of bronchiolar and alveolar respiratory epithelial cells was decreased in SPC/E3-14.7K transgenic mice, indicating decreased epithelial cell proliferation, a finding consistent with the observed reduction in inflammation. CD4 and CD8 lymphocyte populations were only mildly altered, while humoral responses to adenoviral vectors were unchanged in the SPC/E3-14.7K mice. The E3-14.7K protein expressed selectively in respiratory epithelial cells suppresses Ad-induced pulmonary epithelial cell cytotoxicity and lung inflammation in vivo and prolongs reporter gene expression. Host immune responses to first-generation E1–E3-deleted adenoviral vectors administered for gene therapy limit the efficiency and duration of transgene expression. Interestingly, the wild-type adenovirus E3 region encodes a number of genes that function to block host immune responses and thus prolong adenovirus infection. The E3-14.7K gene encodes a protein that blocks TNF-mediated cytotoxicity of adenovirus-infected cells in vitro. However, E3-14.7K function has not been studied in vivo in the absence of other adenoviral E3 proteins. Here, we show that expression of the E3-14.7K gene in the respiratory epithelium of transgenic mice reduces lung inflammation and enhances adenoviral vector gene expression.Keywords
This publication has 53 references indexed in Scilit:
- Prevention of Immune Reactions Triggered by First-Generation Adenoviral Vectors by Monoclonal Antibodies and CTLA4IgHuman Gene Therapy, 1996
- Adenovirus proteins that subvert host defensesTrends in Microbiology, 1994
- Acute Responses of Non-Human Primates to Airway Delivery of an Adenovirus Vector Containing the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNAHuman Gene Therapy, 1994
- In VivoEvaluation of the Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the LungHuman Gene Therapy, 1994
- A case for cytokines as effector molecules in the resolution of virus infectionImmunology Today, 1993
- The adenovirus e3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acidBiochemical and Biophysical Research Communications, 1992
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: Phospholipase activation and deacylation of specific‐membrane phospholipidsJournal of Cellular Physiology, 1990
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986
- An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigensCell, 1985